M.C. Schell

Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

Adjuvant treatment of brain metastases

A new genetic algorithm technique in optimization of permanent prostate implants

Knowledge and intelligent computing system in medicine

A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy

The effect of seed orientation deviations on the quality of¹²⁵I prostate implants

Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method

Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer

Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies

DNA Damage Induced by Vacuum and Soft X-ray Photons from Synchrotron Radiation

Conformity index: A review

The effect of seed anisotropy on brachytherapy dose distributions using 125I and 103Pd

Translation of new cancer treatments from pet dogs to humans

Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer 1 1This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic. Additional participating institutions included Cedar Rapids Oncology Project CCOP, Cedar Rapids, IA; Meritcare Hospital CCOP, Fargo, ND; Sioux Community Cancer Consortium, Sioux Falls, SD; Geisinger Clinical Oncology Program, Danville, PA (Suresh Nair, M.D.); Rapid City Regional Oncology Group, Rapid City, SD (Larry P. Ebbert, M.D.), Saskatchewan Cancer Centre, Saskatoon, Saskatchewan, Canada; Allan Blair Cancer Centre, Regina, Saskatchewan, Canada (Maria Tria Tirona, M.D.); Scottsdale CCOP, Scottsdale, AZ (Tom R. Fitch, M.D.); Carle Cancer Center CCOP, Urbana, IL (Kendrith M. Rowland, M.D.); Medcenter One Health Systems, Bismarck, ND (Ferdinand Addo, M.D.); Altru Health Systems, Grand Forks, ND (Daniel J. Walsh, M.D.); Siouxland Hematology-Oncology Associates, Sioux City, IA (John C. Michalak, M.D.); and CentreCare Clinic, St. Cloud, MN (Harold E. Windschitl, M.D.).

The management of brain metastases

Management of brain metastases

Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results

The use of gold nanoparticles to enhance radiotherapy in mice

Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations

Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases

Radioprotection of the rat small intestine with topical WR-2721

Integral-transport-based deterministic brachytherapy dose calculations

Stereotatic radiosurgery of 468 brain metastases ≤2 cm: implications for SRS dose and whole brain radiation therapy

Image guidance for precise conformal radiotherapy

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

Code of practice for brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 56

A review on genetic algorithm: past, present, and future

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

The american brachytherapy society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis

A prospective pilot study of curative‐intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions

Iododeoxyuridine Radiosensitization by Low- and High-Energy Photons for Brachytherapy Dose Rates

Nearly complete level scheme ofSn116below 4.3 MeV

The Applications of Genetic Algorithms in Medicine

Optical potential and nuclear deformation for even Nd isotopes from fast neutron scattering

ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases

Stereotactic Body Radiation Therapy in Multiple Organ Sites

Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases

Survival and Neurologic Outcomes in a Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation Therapy in Brain Metastases

JENDL-4.0: A New Library for Nuclear Science and Engineering

Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III Trial

Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?

Random-matrix theories in quantum physics: common concepts

Design of Density Functionals by Combining the Method of Constraint Satisfaction with Parametrization for Thermochemistry, Thermochemical Kinetics, and Noncovalent Interactions

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

The neutron optical potential

The Chemistry of Neutron Capture Therapy

Resonant Formation of DNA Strand Breaks by Low-Energy (3 to 20 eV) Electrons

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

Local and global nucleon optical models from 1 keV to 200 MeV

Cure of Fisher Rats Bearing Radioresistant F98 Glioma Treated with cis -Platinum and Irradiated with Monochromatic Synchrotron X-Rays

Photon Activation of Iododeoxyuridine: Biological Efficacy of Auger Electrons

Metastatic Behavior of Breast Cancer Subtypes

Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial

CNS Metastases in Breast Cancer

A genetic algorithm for the optimization of prostate implants

Decision theoretic steering and genetic algorithm optimization: Application to stereotactic radiosurgery treatment planning

Auger electron contribution to bromodeoxyuridine cellular radiosensitization

Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group No. 64

Clinical implications of I-125 dosimetry of bone and bone-soft tissue interfaces

Multi-objective optimization in radiotherapy: applications to stereotactic radiosurgery and prostate brachytherapy

Intraoperative radiotherapy with localized radioprotection: Diminished duodenal toxicity with intraluminal WR2721

Dose broadening due to target position variability during fractionated breath‐held radiation therapy

Intraoperative optimized inverse planning for prostate brachytherapy: early experience

Strong collective excitations in low energy neutron scattering from transitional nuclei

Preliminary report of RTOG 9508: A phase III trial comparing whole brain irradiation alone versus whole brain irradiation plus stereotactic radiosurgery for patients with two or three unresected brain metastases

Direct Excitation of Rotational Levels ofSm152with Low-Energy Neutrons

Stereotactic radiosurgery with whole brain radiation therapy improves survival in patients with brain metastases: report of radiation therapy oncology group phase III study 95–08